Ikarian Capital, LLC
Q4 2024 13F Holdings
- Locationdallas, TX
- Num holdings
171
- Value ($000)
$735,257
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001778253
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KRE SPDR SER TR | S&P BIOTECH | 78464A870 | $67.55M | 9 % | 750,000 | put | |
KRE SPDR SER TR | S&P BIOTECH | 78464A870 | $63.04M | 9 % | 700,000 | call | |
TSN TYSON FOODS INC | CL A | 902494103 | $36.19M | 5 % | 630,000 | put | |
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $33.65M | 5 % | 607,689 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $26.41M | 4 % | 516,431 | ||
AMGN AMGEN INC | COM | 031162100 | $19.29M | 3 % | 74,000 | call | |
BBIO BRIDGEBIO PHARMA INC | COM | 10806X102 | $19.21M | 3 % | 700,000 | call | |
SRRK SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $15.44M | 2 % | 357,185 | ||
BPMC BLUEPRINT MEDICINES CORP | COM | 09627Y109 | $14.77M | 2 % | 169,374 | ||
FORTE BIOSCIENCES INC | COM NEW | 34962G208 | $13.84M | 2 % | 609,225 |
Rows Per Page
1 - 10 of 17110
- 10
- 50
- 100